Enhancing Cancer Treatment with G-CSF and Photofrin®
Author Information
Author(s): Golab J, Wilczynski G, Zagozdzon R, Stoklosa T, Dabrowska A, Rybczynska J, Wasik M, Machaj E, Oldak T, Kozar K, Kaminski R, Giermasz A, Czajka A, Lasek W, Feleszko W, Jakobisiak M
Primary Institution: Department of Immunology, Institute of Biostructure, Warsaw, Poland
Hypothesis
Does the combination of G-CSF and Photofrin® enhance the anti-tumour effects of photodynamic therapy in mice?
Conclusion
The combination of G-CSF and Photofrin® significantly improves the anti-tumour effects and survival rates in mice with cancer.
Supporting Evidence
- G-CSF treatment significantly enhanced the anti-tumour effectiveness of Photofrin®-based PDT.
- 33% of mice with colon-26 tumors were completely cured after the combined therapy.
- Combined treatment resulted in more neutrophils and apoptotic cells in the tumors compared to either treatment alone.
- Simultaneous administration of Photofrin® and G-CSF stimulated myelopoiesis in bone marrow and spleen.
Takeaway
This study found that using a special treatment called G-CSF along with a light therapy for cancer helped mice fight their tumors better.
Methodology
The study evaluated the effects of G-CSF combined with Photofrin® on tumour growth and neutrophil activity in mice.
Participant Demographics
Mice bearing colon-26 and Lewis lung carcinoma tumors.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website